(-)-Syringaresinol is isolated from the rhizomes of Polygonatum kingianum. DL-Syringaresinol inhibits the proliferation of human promyelocytic HL-60 cells through G(1) arrest and induction of apoptosis, may be a potential chemotherapeutic agent for the treatment of cancer.